Akiko Futamura Ph.D Overview
- Firm
- G4S Capital and...
- Primary Position
-
Director and CSO
Akiko Futamura Ph.D General Information
Biography
Dr. Akiko Futamura served as Director and CSO at G4S Capital and Ikigai Accelerator. She served as President & Chief Executive Officer at Carna Biosciences. She is the Chief Executive Officer at InfiniteBio. She has an extensive background in the business and science of biotechnology and has worked for over 30 Japanese and US Life science companies as an advisor/consultant. Dr. Futamura previously served as the President and CEO of CarnaBio USA, the US subsidiary of Carna Biosciences from 2013-2017, where she led multiple successful drug licensing and collaboration deals with companies such as Johnson and Johnson and Gilead Sciences.
Contact Information
Akiko Futamura Ph.D FAQs
-
Who is Akiko Futamura Ph.D?
Dr. Akiko Futamura served as Director and CSO at G4S Capital and Ikigai Accelerator.
-
How much does Akiko Futamura Ph.D typically invest?
Akiko Futamura Ph.D's median deal size is
. -
What is Akiko Futamura Ph.D’s main position?
Akiko Futamura Ph.D’s primary position is Director and CSO.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »